This Article Full Text Full Text (PDF) All Versions of this Article: 46/5/1086    most recent 01.HYP.0000187900.36455.4cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, S. H. Articles by Koh, K. K. Search for Related Content PubMed PubMed Citation Articles by Han, S. H. Articles by Koh, K. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Primary prevention Pathophysiology Type 2 diabetes Clinical Studies Mechanism of atherosclerosis/growth factors

(Hypertension. 2005;46:1086.)
© 2005 American Heart Association, Inc.

Brief Reviews

Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor- Activators

From the Division of Cardiology (S.H.H., K.K.K.), Gil Heart Center, Gachon Medical School, Incheon, Korea, and the Diabetes Unit (M.J.Q.), Laboratory of Clinical Investigation, NCCAM, NIH, Bethesda, Md.

Correspondence to Kwang Kon Koh, MD, PhD, Division of Cardiology, Gil Heart Center, Gachon Medical School, 1198 Kuwol-dong, Namdong-gu, Incheon, South Korea 405-760. E-mail kwangk{at}ghil.com

Fibric acid is a synthetic ligand of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)- that is highly expressed in skeletal muscle and heart, where it promotes ß-oxidation of fatty acids to mediate hypolipidemic actions. PPAR- regulates expression of key proteins involved in atherogenesis, vascular inflammation, plaque instability, and thrombosis. Thus, PPAR- may exert direct antiatherogenic actions in the vascular wall. Endothelial dysfunction associated with the metabolic syndrome and other insulin-resistant states is characterized by impaired insulin-stimulated nitric oxide production from the endothelium and decreased blood flow to skeletal muscle. Thus, improvement in insulin sensitivity leads to improved endothelial function. This may be an additional mechanism whereby fibrates decrease the incidence of coronary heart disease. Adiponectin is a protein secreted specifically by adipose cells that may couple regulation of insulin sensitivity with energy metabolism and serve to link obesity with insulin resistance. In this review, we discuss the mechanisms underlying the vascular and metabolic effects of fibrates that may act synergistically to prevent or regress atherosclerosis and coronary heart disease.

Key Words: fibrates • endothelium • adipose tissue • insulin resistance • cardiovascular diseases

This article has been cited by other articles:

				K. K. Koh, P. C. Oh, and M. J. Quon Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res, March 1, 2009; 81(4): 649 - 659. [Abstract] [Full Text] [PDF]

				J. R. Ussher and G. D. Lopaschuk The malonyl CoA axis as a potential target for treating ischaemic heart disease Cardiovasc Res, July 15, 2008; 79(2): 259 - 268. [Abstract] [Full Text] [PDF]

				E. M. Horvath, L. Tackett, A. M. McCarthy, P. Raman, J. T. Brozinick, and J. S. Elmendorf Antidiabetogenic Effects of Chromium Mitigate Hyperinsulinemia-Induced Cellular Insulin Resistance via Correction of Plasma Membrane Cholesterol Imbalance Mol. Endocrinol., April 1, 2008; 22(4): 937 - 950. [Abstract] [Full Text] [PDF]

				J. D. Knudson, G. M. Dick, and J. D. Tune Adipokines and Coronary Vasomotor Dysfunction Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736. [Abstract] [Full Text] [PDF]

				M. A. Yakubu, R. H. Nsaif, and A. O. Oyekan Peroxisome Proliferator-Activated Receptor {alpha} Activation-Mediated Regulation of Endothelin-1 Production via Nitric Oxide and Protein Kinase C Signaling Pathways in Piglet Cerebral Microvascular Endothelial Cell Culture J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 774 - 781. [Abstract] [Full Text] [PDF]

				B. N. Finck The PPAR regulatory system in cardiac physiology and disease Cardiovasc Res, January 15, 2007; 73(2): 269 - 277. [Abstract] [Full Text] [PDF]

				E. Bertrand, C. Fritsch, S. Diether, G. Lambrou, D. Muller, F. Schaeffel, P. Schindler, K. L. Schmid, J. van Oostrum, and H. Voshol Identification of Apolipoprotein A-I as a "STOP" Signal for Myopia Mol. Cell. Proteomics, November 1, 2006; 5(11): 2158 - 2166. [Abstract] [Full Text] [PDF]